Vanguard Capital Management
IDXX icon

Vanguard Capital Management’s Idexx Laboratories IDXX Stock Holding History

Vanguard Capital Management’s Portfolio IDXX Stock Details IDXX Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$2.71B Sell
5,152,213
-30,294
-0.6% -$17M 0.06% 265
2026
Q1 		$2.91B Buy
+5,182,507
New +$3.32B 0.07% 231

Other funds holding IDXX

BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
Vanguard Portfolio Management
Vanguard Portfolio Management Malvern, Pennsylvania $2.22T AUM
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return
Invesco
Invesco Atlanta, Georgia $1.26T AUM 61.52% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return
BAMCO Inc
BAMCO Inc New York $66.6B AUM 7.35% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.89T AUM 35.08% 1-Year Est. Return
Bank of New York Mellon
Bank of New York Mellon New York $609B AUM 40.19% 1-Year Est. Return
Arrowstreet Capital
Arrowstreet Capital Boston, Massachusetts $225B AUM 49.49% 1-Year Est. Return
Fundsmith LLP
Fundsmith LLP London, United Kingdom $13.6B AUM 7.6% 1-Year Est. Return

Vanguard Capital Management's IDXX Position: Q2 2026 in Review

Vanguard Capital Management reduced its Idexx Laboratories (IDXX) stake by 0.58% in Q2 2026, selling an estimated $17M and leaving 5,152,213 shares worth $2.71B. The position accounts for 0.06% of the portfolio, ranked #265.

Vanguard Capital Management first reported a position in IDXX in Q1 2026 and has held it in 2 quarters since. The position peaked at $2.91B in Q1 2026. 1,231 funds tracked by Wall St. Rank hold IDXX as of Q2 2026.

  • Vanguard Capital Management held 5,152,213 shares of Idexx Laboratories worth $2.71B as of Q2 2026.
  • Vanguard Capital Management sold 30,294 Idexx Laboratories shares in Q2 2026, an estimated $17M.
  • Idexx Laboratories made up 0.06% of Vanguard Capital Management's portfolio in Q2 2026, its #265 holding.
  • Vanguard Capital Management first reported a position in Idexx Laboratories in Q1 2026 and has held it in 2 quarters since.
  • Vanguard Capital Management's Idexx Laboratories position peaked at $2.91B in Q1 2026.
  • 1,231 funds tracked by Wall St. Rank held Idexx Laboratories as of Q2 2026.

Based on Vanguard Capital Management's 13F filing for Q2 2026, filed 13 Aug 2026.